Your browser doesn't support javascript.
loading
Asymmetric dimethylarginine as a potential biomarker for management and follow-up of phenylketonuria.
Andrade, Fernando; Villate, Olatz; Couce, María L; Bueno, María A; Alcalde, Carlos; de Las Heras, Javier; Ceberio, Leticia; Núñez-Marcos, Sergio; Nambo, Pablo Suárez; Aldámiz-Echevarría, Luis.
Affiliation
  • Andrade F; Group of Metabolism, Biocruces Bizkaia Health Research Institute, CIBER de Enfermedades Raras (CIBERER), Plaza de Cruces 12, 48903, Barakaldo, Spain.
  • Villate O; Group of Metabolism, Biocruces Bizkaia Health Research Institute, CIBER de Enfermedades Raras (CIBERER), Plaza de Cruces 12, 48903, Barakaldo, Spain.
  • Couce ML; Metabolic Disorders Unit, Santiago de Compostela University Hospital, IDIS, CIBERER, Travesía de Choupana s/n, 15706, Santiago de Compostela, Spain.
  • Bueno MA; Metabolic Disorders, Dietetics and Nutrition Unit, Virgen del Rocío University Hospital, Manuel Siurot Avenue, s/n, 41013, Sevilla, Spain.
  • Alcalde C; Paediatrics Unit, Río Hortega University Hospital, Calle Dulzaina 2, 47012, Valladolid, Spain.
  • de Las Heras J; Group of Metabolism, Biocruces Bizkaia Health Research Institute, CIBER de Enfermedades Raras (CIBERER), Plaza de Cruces 12, 48903, Barakaldo, Spain.
  • Ceberio L; Division of Pediatric Metabolism, University Cruces Hospital, Barakaldo, Spain.
  • Núñez-Marcos S; University of the Basque Country (UPV/EHU), Barakaldo, Spain.
  • Nambo PS; Group of Metabolism, Biocruces Bizkaia Health Research Institute, CIBER de Enfermedades Raras (CIBERER), Plaza de Cruces 12, 48903, Barakaldo, Spain.
  • Aldámiz-Echevarría L; Department of Internal Medicine, University Cruces Hospital, Barakaldo, Spain.
Eur J Pediatr ; 178(6): 903-911, 2019 Jun.
Article in En | MEDLINE | ID: mdl-30941500
ABSTRACT
Phenylketonuria's (PKU) treatment based on low-protein diet may affect other metabolic pathways, such as that of asymmetric dimethylarginine (ADMA). The aim of this study was to evaluate the reliability of ADMA as a biomarker of adequate metabolic control and possible nutritional risk in a long-term PKU patient population. One hundred and six dietary-treated PKU patients from four hospitals in Spain were enrolled in this cross-sectional study. Their lipid profile, total homocysteine, ADMA, and symmetric dimethylarginine (SDMA) concentrations were analyzed and compared with a control group. Sensitivity, specificity, and likelihood ratios of the proposed biomarker were calculated. PKU patients had statistically significant lower plasmatic ADMA, SDMA, and arginine concentrations as compared with the control group (p < 0.001). Significant correlations were found between ADMA, phenylalanine, and total homocysteine levels. The ADMA/creatinine ratio correlated with phenylalanine levels as metabolic control and nutritional risk in PKU patients. Its reliability as a management biomarker was studied with positive results. The ADMA/creatinine ratio might serve as an independent biomarker in the management of PKU patients, different from blood phenylalanine levels. It could be of particular usefulness to detect those who are following an unbalanced diet that could have long-term negative effects.

Conclusion:

In this study, we have evaluated the reliability of ADMA as a potential biomarker of adequate metabolic control and possible nutritional risk in a long-term PKU patient population. What is Known • Although PKU individuals have lower values of ADMA even with blood Phe levels in the recommended range, little attention is payed to other metabolic pathways. What is New • ADMA could be used as new biomarker for PKU management and follow-up of the diet, after evaluating their reliability in a long-term PKU patient population.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylketonurias / Arginine Type of study: Clinical_trials / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Child / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Eur J Pediatr Year: 2019 Type: Article Affiliation country: Spain

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylketonurias / Arginine Type of study: Clinical_trials / Observational_studies / Prevalence_studies / Risk_factors_studies Limits: Child / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: Eur J Pediatr Year: 2019 Type: Article Affiliation country: Spain